data monitoring committee News
Most Popular data monitoring committee Story
HGS stock dives on drug safety concerns
Human Genome Sciences watched its stock take a dive this morning after an independent data monitoring committee noted lung-related side effects in patients receiving 1200-microgram injections of the Read more...
Latest Headlines
- January 23, 2008
- October 10, 2007
- October 24, 2006
- September 11, 2006
- August 7, 2006
- August 3, 2006
- July 27, 2006
- June 20, 2006
- March 5, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
